nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ABCB1—Tamoxifen—pancreatic cancer	0.103	0.199	CbGbCtD
Atenolol—ABCB1—Gemcitabine—pancreatic cancer	0.0887	0.172	CbGbCtD
Atenolol—ABCB1—Erlotinib—pancreatic cancer	0.0875	0.169	CbGbCtD
Atenolol—ABCB1—Irinotecan—pancreatic cancer	0.079	0.153	CbGbCtD
Atenolol—ABCB1—Docetaxel—pancreatic cancer	0.0579	0.112	CbGbCtD
Atenolol—ABCB1—Sunitinib—pancreatic cancer	0.0576	0.112	CbGbCtD
Atenolol—ABCB1—Doxorubicin—pancreatic cancer	0.0432	0.0835	CbGbCtD
Atenolol—Ibuprofen—CXCL8—pancreatic cancer	0.00154	0.379	CrCbGaD
Atenolol—Ibuprofen—PPARG—pancreatic cancer	0.00106	0.262	CrCbGaD
Atenolol—Chlorphenesin—PTGS2—pancreatic cancer	0.00101	0.248	CrCbGaD
Atenolol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000635	0.00148	CcSEcCtD
Atenolol—Confusional state—Fluorouracil—pancreatic cancer	0.000635	0.00148	CcSEcCtD
Atenolol—Body temperature increased—Sunitinib—pancreatic cancer	0.000631	0.00147	CcSEcCtD
Atenolol—Diarrhoea—Erlotinib—pancreatic cancer	0.00063	0.00147	CcSEcCtD
Atenolol—Oedema—Fluorouracil—pancreatic cancer	0.000629	0.00146	CcSEcCtD
Atenolol—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000627	0.00146	CcSEcCtD
Atenolol—Anorexia—Irinotecan—pancreatic cancer	0.000626	0.00146	CcSEcCtD
Atenolol—Pain in extremity—Epirubicin—pancreatic cancer	0.000623	0.00145	CcSEcCtD
Atenolol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000619	0.00144	CcSEcCtD
Atenolol—Hot flush—Doxorubicin—pancreatic cancer	0.000617	0.00143	CcSEcCtD
Atenolol—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000616	0.00143	CcSEcCtD
Atenolol—Visual impairment—Docetaxel—pancreatic cancer	0.000616	0.00143	CcSEcCtD
Atenolol—Dizziness—Tamoxifen—pancreatic cancer	0.000616	0.00143	CcSEcCtD
Atenolol—Tachycardia—Fluorouracil—pancreatic cancer	0.000614	0.00143	CcSEcCtD
Atenolol—Hypotension—Irinotecan—pancreatic cancer	0.000614	0.00143	CcSEcCtD
Atenolol—Affect lability—Epirubicin—pancreatic cancer	0.000614	0.00143	CcSEcCtD
Atenolol—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000611	0.00142	CcSEcCtD
Atenolol—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000611	0.00142	CcSEcCtD
Atenolol—Anorexia—Gemcitabine—pancreatic cancer	0.00061	0.00142	CcSEcCtD
Atenolol—Dizziness—Erlotinib—pancreatic cancer	0.000609	0.00142	CcSEcCtD
Atenolol—Anorexia—Fluorouracil—pancreatic cancer	0.0006	0.00139	CcSEcCtD
Atenolol—Purpura—Doxorubicin—pancreatic cancer	0.000598	0.00139	CcSEcCtD
Atenolol—Hypotension—Gemcitabine—pancreatic cancer	0.000598	0.00139	CcSEcCtD
Atenolol—Insomnia—Irinotecan—pancreatic cancer	0.000594	0.00138	CcSEcCtD
Atenolol—Flushing—Docetaxel—pancreatic cancer	0.000593	0.00138	CcSEcCtD
Atenolol—Cardiac arrest—Epirubicin—pancreatic cancer	0.000593	0.00138	CcSEcCtD
Atenolol—Cardiac failure—Doxorubicin—pancreatic cancer	0.000591	0.00137	CcSEcCtD
Atenolol—Mood swings—Epirubicin—pancreatic cancer	0.00059	0.00137	CcSEcCtD
Atenolol—Paraesthesia—Irinotecan—pancreatic cancer	0.00059	0.00137	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—pancreatic cancer	0.000589	0.00137	CcSEcCtD
Atenolol—Hypotension—Fluorouracil—pancreatic cancer	0.000588	0.00137	CcSEcCtD
Atenolol—Rash—Tamoxifen—pancreatic cancer	0.000587	0.00137	CcSEcCtD
Atenolol—Dermatitis—Tamoxifen—pancreatic cancer	0.000587	0.00136	CcSEcCtD
Atenolol—Ataxia—Epirubicin—pancreatic cancer	0.000586	0.00136	CcSEcCtD
Atenolol—Dyspnoea—Irinotecan—pancreatic cancer	0.000586	0.00136	CcSEcCtD
Atenolol—Somnolence—Irinotecan—pancreatic cancer	0.000584	0.00136	CcSEcCtD
Atenolol—Headache—Tamoxifen—pancreatic cancer	0.000583	0.00136	CcSEcCtD
Atenolol—Rash—Erlotinib—pancreatic cancer	0.000581	0.00135	CcSEcCtD
Atenolol—Dermatitis—Erlotinib—pancreatic cancer	0.00058	0.00135	CcSEcCtD
Atenolol—Insomnia—Gemcitabine—pancreatic cancer	0.000579	0.00135	CcSEcCtD
Atenolol—Dyspepsia—Irinotecan—pancreatic cancer	0.000578	0.00134	CcSEcCtD
Atenolol—Headache—Erlotinib—pancreatic cancer	0.000577	0.00134	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—pancreatic cancer	0.000577	0.00134	CcSEcCtD
Atenolol—Paraesthesia—Gemcitabine—pancreatic cancer	0.000575	0.00134	CcSEcCtD
Atenolol—Asthenia—Sunitinib—pancreatic cancer	0.000572	0.00133	CcSEcCtD
Atenolol—Decreased appetite—Irinotecan—pancreatic cancer	0.000571	0.00133	CcSEcCtD
Atenolol—Arrhythmia—Docetaxel—pancreatic cancer	0.000571	0.00133	CcSEcCtD
Atenolol—Dyspnoea—Gemcitabine—pancreatic cancer	0.000571	0.00133	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000569	0.00132	CcSEcCtD
Atenolol—Insomnia—Fluorouracil—pancreatic cancer	0.000569	0.00132	CcSEcCtD
Atenolol—Somnolence—Gemcitabine—pancreatic cancer	0.000569	0.00132	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—pancreatic cancer	0.000568	0.00132	CcSEcCtD
Atenolol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000567	0.00132	CcSEcCtD
Atenolol—Fatigue—Irinotecan—pancreatic cancer	0.000566	0.00132	CcSEcCtD
Atenolol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000565	0.00131	CcSEcCtD
Atenolol—Alopecia—Docetaxel—pancreatic cancer	0.000565	0.00131	CcSEcCtD
Atenolol—Pruritus—Sunitinib—pancreatic cancer	0.000564	0.00131	CcSEcCtD
Atenolol—Pain—Irinotecan—pancreatic cancer	0.000562	0.00131	CcSEcCtD
Atenolol—Constipation—Irinotecan—pancreatic cancer	0.000562	0.00131	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000561	0.0013	CcSEcCtD
Atenolol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000561	0.0013	CcSEcCtD
Atenolol—Somnolence—Fluorouracil—pancreatic cancer	0.000559	0.0013	CcSEcCtD
Atenolol—Decreased appetite—Gemcitabine—pancreatic cancer	0.000556	0.00129	CcSEcCtD
Atenolol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000554	0.00129	CcSEcCtD
Atenolol—Nausea—Tamoxifen—pancreatic cancer	0.000553	0.00129	CcSEcCtD
Atenolol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000553	0.00128	CcSEcCtD
Atenolol—Fatigue—Gemcitabine—pancreatic cancer	0.000552	0.00128	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000548	0.00127	CcSEcCtD
Atenolol—Constipation—Gemcitabine—pancreatic cancer	0.000547	0.00127	CcSEcCtD
Atenolol—Pain—Gemcitabine—pancreatic cancer	0.000547	0.00127	CcSEcCtD
Atenolol—Nausea—Erlotinib—pancreatic cancer	0.000547	0.00127	CcSEcCtD
Atenolol—Decreased appetite—Fluorouracil—pancreatic cancer	0.000547	0.00127	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—pancreatic cancer	0.000546	0.00127	CcSEcCtD
Atenolol—Diarrhoea—Sunitinib—pancreatic cancer	0.000546	0.00127	CcSEcCtD
Atenolol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000543	0.00126	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—pancreatic cancer	0.000542	0.00126	CcSEcCtD
Atenolol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000541	0.00126	CcSEcCtD
Atenolol—Pain—Fluorouracil—pancreatic cancer	0.000538	0.00125	CcSEcCtD
Atenolol—Dizziness—Sunitinib—pancreatic cancer	0.000527	0.00123	CcSEcCtD
Atenolol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000527	0.00123	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000527	0.00122	CcSEcCtD
Atenolol—Body temperature increased—Irinotecan—pancreatic cancer	0.000519	0.00121	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000519	0.00121	CcSEcCtD
Atenolol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000519	0.00121	CcSEcCtD
Atenolol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000506	0.00118	CcSEcCtD
Atenolol—Rash—Sunitinib—pancreatic cancer	0.000503	0.00117	CcSEcCtD
Atenolol—Dermatitis—Sunitinib—pancreatic cancer	0.000502	0.00117	CcSEcCtD
Atenolol—Headache—Sunitinib—pancreatic cancer	0.0005	0.00116	CcSEcCtD
Atenolol—Syncope—Docetaxel—pancreatic cancer	0.000499	0.00116	CcSEcCtD
Atenolol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000497	0.00116	CcSEcCtD
Atenolol—Palpitations—Docetaxel—pancreatic cancer	0.000492	0.00114	CcSEcCtD
Atenolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000489	0.00114	CcSEcCtD
Atenolol—Cough—Docetaxel—pancreatic cancer	0.000486	0.00113	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—pancreatic cancer	0.00048	0.00112	CcSEcCtD
Atenolol—Chest pain—Docetaxel—pancreatic cancer	0.000474	0.0011	CcSEcCtD
Atenolol—Nausea—Sunitinib—pancreatic cancer	0.000474	0.0011	CcSEcCtD
Atenolol—Renal failure—Epirubicin—pancreatic cancer	0.000472	0.0011	CcSEcCtD
Atenolol—Asthenia—Irinotecan—pancreatic cancer	0.000471	0.0011	CcSEcCtD
Atenolol—Dry mouth—Docetaxel—pancreatic cancer	0.000463	0.00108	CcSEcCtD
Atenolol—Sweating—Epirubicin—pancreatic cancer	0.00046	0.00107	CcSEcCtD
Atenolol—Asthenia—Gemcitabine—pancreatic cancer	0.000459	0.00107	CcSEcCtD
Atenolol—Confusional state—Docetaxel—pancreatic cancer	0.000458	0.00106	CcSEcCtD
Atenolol—Oedema—Docetaxel—pancreatic cancer	0.000454	0.00106	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—pancreatic cancer	0.000453	0.00105	CcSEcCtD
Atenolol—Pruritus—Gemcitabine—pancreatic cancer	0.000453	0.00105	CcSEcCtD
Atenolol—Diarrhoea—Irinotecan—pancreatic cancer	0.00045	0.00105	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—pancreatic cancer	0.000449	0.111	CrCbGaD
Atenolol—Agranulocytosis—Epirubicin—pancreatic cancer	0.000448	0.00104	CcSEcCtD
Atenolol—Shock—Docetaxel—pancreatic cancer	0.000447	0.00104	CcSEcCtD
Atenolol—Pruritus—Fluorouracil—pancreatic cancer	0.000445	0.00104	CcSEcCtD
Atenolol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000445	0.00103	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—pancreatic cancer	0.000444	0.00103	CcSEcCtD
Atenolol—Tachycardia—Docetaxel—pancreatic cancer	0.000443	0.00103	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—pancreatic cancer	0.000439	0.00102	CcSEcCtD
Atenolol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000438	0.00102	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—pancreatic cancer	0.000437	0.00102	CcSEcCtD
Atenolol—Dizziness—Irinotecan—pancreatic cancer	0.000434	0.00101	CcSEcCtD
Atenolol—Anorexia—Docetaxel—pancreatic cancer	0.000433	0.00101	CcSEcCtD
Atenolol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000431	0.001	CcSEcCtD
Atenolol—Sweating—Doxorubicin—pancreatic cancer	0.000426	0.000991	CcSEcCtD
Atenolol—Hypotension—Docetaxel—pancreatic cancer	0.000424	0.000987	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—pancreatic cancer	0.000419	0.000975	CcSEcCtD
Atenolol—Dizziness—Fluorouracil—pancreatic cancer	0.000416	0.000967	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—pancreatic cancer	0.000416	0.000966	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000415	0.000964	CcSEcCtD
Atenolol—Rash—Irinotecan—pancreatic cancer	0.000414	0.000963	CcSEcCtD
Atenolol—Dermatitis—Irinotecan—pancreatic cancer	0.000414	0.000962	CcSEcCtD
Atenolol—Headache—Irinotecan—pancreatic cancer	0.000412	0.000957	CcSEcCtD
Atenolol—Insomnia—Docetaxel—pancreatic cancer	0.000411	0.000955	CcSEcCtD
Atenolol—Paraesthesia—Docetaxel—pancreatic cancer	0.000408	0.000948	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—pancreatic cancer	0.000406	0.000944	CcSEcCtD
Atenolol—Dyspnoea—Docetaxel—pancreatic cancer	0.000405	0.000941	CcSEcCtD
Atenolol—Somnolence—Docetaxel—pancreatic cancer	0.000404	0.000939	CcSEcCtD
Atenolol—Rash—Gemcitabine—pancreatic cancer	0.000404	0.000938	CcSEcCtD
Atenolol—Dermatitis—Gemcitabine—pancreatic cancer	0.000403	0.000937	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—pancreatic cancer	0.000402	0.000935	CcSEcCtD
Atenolol—Headache—Gemcitabine—pancreatic cancer	0.000401	0.000932	CcSEcCtD
Atenolol—Flushing—Epirubicin—pancreatic cancer	0.0004	0.00093	CcSEcCtD
Atenolol—Dyspepsia—Docetaxel—pancreatic cancer	0.0004	0.000929	CcSEcCtD
Atenolol—Rash—Fluorouracil—pancreatic cancer	0.000397	0.000922	CcSEcCtD
Atenolol—Dermatitis—Fluorouracil—pancreatic cancer	0.000396	0.000922	CcSEcCtD
Atenolol—Decreased appetite—Docetaxel—pancreatic cancer	0.000395	0.000918	CcSEcCtD
Atenolol—Headache—Fluorouracil—pancreatic cancer	0.000394	0.000917	CcSEcCtD
Atenolol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000392	0.000912	CcSEcCtD
Atenolol—Fatigue—Docetaxel—pancreatic cancer	0.000392	0.00091	CcSEcCtD
Atenolol—Nausea—Irinotecan—pancreatic cancer	0.00039	0.000907	CcSEcCtD
Atenolol—Constipation—Docetaxel—pancreatic cancer	0.000388	0.000903	CcSEcCtD
Atenolol—Pain—Docetaxel—pancreatic cancer	0.000388	0.000903	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—pancreatic cancer	0.000385	0.000896	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—pancreatic cancer	0.000384	0.000894	CcSEcCtD
Atenolol—Alopecia—Epirubicin—pancreatic cancer	0.000381	0.000886	CcSEcCtD
Atenolol—Nausea—Gemcitabine—pancreatic cancer	0.00038	0.000884	CcSEcCtD
Atenolol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000374	0.00087	CcSEcCtD
Atenolol—Nausea—Fluorouracil—pancreatic cancer	0.000374	0.000869	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—pancreatic cancer	0.000372	0.000865	CcSEcCtD
Atenolol—Flushing—Doxorubicin—pancreatic cancer	0.00037	0.000861	CcSEcCtD
Atenolol—Tension—Epirubicin—pancreatic cancer	0.000368	0.000856	CcSEcCtD
Atenolol—Nervousness—Epirubicin—pancreatic cancer	0.000365	0.000848	CcSEcCtD
Atenolol—Body temperature increased—Docetaxel—pancreatic cancer	0.000359	0.000835	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000356	0.000829	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—pancreatic cancer	0.000354	0.000822	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—pancreatic cancer	0.000353	0.00082	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000348	0.00081	CcSEcCtD
Atenolol—Tension—Doxorubicin—pancreatic cancer	0.000341	0.000792	CcSEcCtD
Atenolol—Malaise—Epirubicin—pancreatic cancer	0.000339	0.000787	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—pancreatic cancer	0.000337	0.000784	CcSEcCtD
Atenolol—Vertigo—Epirubicin—pancreatic cancer	0.000337	0.000784	CcSEcCtD
Atenolol—Syncope—Epirubicin—pancreatic cancer	0.000337	0.000783	CcSEcCtD
Atenolol—Palpitations—Epirubicin—pancreatic cancer	0.000332	0.000771	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.00033	0.000767	CcSEcCtD
Atenolol—Cough—Epirubicin—pancreatic cancer	0.000328	0.000762	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—pancreatic cancer	0.000327	0.000761	CcSEcCtD
Atenolol—Asthenia—Docetaxel—pancreatic cancer	0.000326	0.000758	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000322	0.000749	CcSEcCtD
Atenolol—Pruritus—Docetaxel—pancreatic cancer	0.000321	0.000747	CcSEcCtD
Atenolol—Chest pain—Epirubicin—pancreatic cancer	0.00032	0.000743	CcSEcCtD
Atenolol—Anxiety—Epirubicin—pancreatic cancer	0.000318	0.00074	CcSEcCtD
Atenolol—Discomfort—Epirubicin—pancreatic cancer	0.000316	0.000734	CcSEcCtD
Atenolol—Malaise—Doxorubicin—pancreatic cancer	0.000313	0.000728	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—pancreatic cancer	0.000313	0.000727	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—pancreatic cancer	0.000312	0.000725	CcSEcCtD
Atenolol—Syncope—Doxorubicin—pancreatic cancer	0.000311	0.000724	CcSEcCtD
Atenolol—Diarrhoea—Docetaxel—pancreatic cancer	0.000311	0.000722	CcSEcCtD
Atenolol—Confusional state—Epirubicin—pancreatic cancer	0.000309	0.000718	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—pancreatic cancer	0.000307	0.000714	CcSEcCtD
Atenolol—Oedema—Epirubicin—pancreatic cancer	0.000306	0.000712	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000305	0.00071	CcSEcCtD
Atenolol—Cough—Doxorubicin—pancreatic cancer	0.000303	0.000705	CcSEcCtD
Atenolol—Shock—Epirubicin—pancreatic cancer	0.000301	0.000701	CcSEcCtD
Atenolol—Dizziness—Docetaxel—pancreatic cancer	0.0003	0.000698	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.0003	0.000697	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—pancreatic cancer	0.000299	0.000695	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000296	0.000689	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—pancreatic cancer	0.000296	0.000687	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—pancreatic cancer	0.000295	0.000685	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—pancreatic cancer	0.000292	0.000679	CcSEcCtD
Atenolol—Anorexia—Epirubicin—pancreatic cancer	0.000292	0.000679	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—pancreatic cancer	0.000289	0.000672	CcSEcCtD
Atenolol—Rash—Docetaxel—pancreatic cancer	0.000286	0.000666	CcSEcCtD
Atenolol—Hypotension—Epirubicin—pancreatic cancer	0.000286	0.000666	CcSEcCtD
Atenolol—Dermatitis—Docetaxel—pancreatic cancer	0.000286	0.000665	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—pancreatic cancer	0.000286	0.000664	CcSEcCtD
Atenolol—Headache—Docetaxel—pancreatic cancer	0.000285	0.000662	CcSEcCtD
Atenolol—Oedema—Doxorubicin—pancreatic cancer	0.000283	0.000659	CcSEcCtD
Atenolol—Shock—Doxorubicin—pancreatic cancer	0.000279	0.000648	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000278	0.000645	CcSEcCtD
Atenolol—Insomnia—Epirubicin—pancreatic cancer	0.000277	0.000644	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—pancreatic cancer	0.000277	0.000643	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—pancreatic cancer	0.000275	0.00064	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000274	0.000637	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—pancreatic cancer	0.000273	0.000635	CcSEcCtD
Atenolol—Somnolence—Epirubicin—pancreatic cancer	0.000272	0.000633	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—pancreatic cancer	0.00027	0.000628	CcSEcCtD
Atenolol—Nausea—Docetaxel—pancreatic cancer	0.00027	0.000627	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—pancreatic cancer	0.00027	0.000627	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—pancreatic cancer	0.000266	0.000619	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—pancreatic cancer	0.000265	0.000616	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000264	0.000615	CcSEcCtD
Atenolol—Fatigue—Epirubicin—pancreatic cancer	0.000264	0.000614	CcSEcCtD
Atenolol—Constipation—Epirubicin—pancreatic cancer	0.000262	0.000609	CcSEcCtD
Atenolol—Pain—Epirubicin—pancreatic cancer	0.000262	0.000609	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—pancreatic cancer	0.000256	0.000596	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000255	0.000592	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000253	0.000588	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000252	0.000587	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—pancreatic cancer	0.000252	0.000586	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—pancreatic cancer	0.00025	0.00058	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000246	0.000573	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000245	0.000569	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—pancreatic cancer	0.000244	0.000568	CcSEcCtD
Atenolol—Constipation—Doxorubicin—pancreatic cancer	0.000242	0.000564	CcSEcCtD
Atenolol—Pain—Doxorubicin—pancreatic cancer	0.000242	0.000564	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—pancreatic cancer	0.000242	0.000563	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000234	0.000543	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000224	0.000521	CcSEcCtD
Atenolol—Asthenia—Epirubicin—pancreatic cancer	0.00022	0.000511	CcSEcCtD
Atenolol—Pruritus—Epirubicin—pancreatic cancer	0.000217	0.000504	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—pancreatic cancer	0.00021	0.000487	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—pancreatic cancer	0.000203	0.000473	CcSEcCtD
Atenolol—Dizziness—Epirubicin—pancreatic cancer	0.000203	0.000471	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—pancreatic cancer	0.000201	0.000466	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000194	0.000451	CcSEcCtD
Atenolol—Rash—Epirubicin—pancreatic cancer	0.000193	0.000449	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—pancreatic cancer	0.000193	0.000449	CcSEcCtD
Atenolol—Headache—Epirubicin—pancreatic cancer	0.000192	0.000446	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—pancreatic cancer	0.000187	0.000436	CcSEcCtD
Atenolol—Nausea—Epirubicin—pancreatic cancer	0.000182	0.000423	CcSEcCtD
Atenolol—Rash—Doxorubicin—pancreatic cancer	0.000179	0.000416	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—pancreatic cancer	0.000179	0.000415	CcSEcCtD
Atenolol—Headache—Doxorubicin—pancreatic cancer	0.000178	0.000413	CcSEcCtD
Atenolol—Nausea—Doxorubicin—pancreatic cancer	0.000168	0.000391	CcSEcCtD
Atenolol—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	9.44e-05	0.00193	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	9.44e-05	0.00193	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	9.43e-05	0.00193	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	9.29e-05	0.0019	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	9.22e-05	0.00188	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	9.01e-05	0.00184	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	8.99e-05	0.00184	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	8.82e-05	0.0018	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	8.8e-05	0.0018	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	8.76e-05	0.00179	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	8.76e-05	0.00179	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	8.63e-05	0.00176	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	8.62e-05	0.00176	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	8.57e-05	0.00175	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	8.57e-05	0.00175	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	8.55e-05	0.00175	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	8.47e-05	0.00173	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	8.47e-05	0.00173	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	8.43e-05	0.00172	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	8.36e-05	0.00171	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	8.29e-05	0.00169	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	8.29e-05	0.00169	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	8.2e-05	0.00168	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	8.03e-05	0.00164	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	7.92e-05	0.00162	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	7.86e-05	0.00161	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	7.76e-05	0.00159	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	7.69e-05	0.00157	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	7.66e-05	0.00157	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	7.66e-05	0.00157	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	7.59e-05	0.00155	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	7.5e-05	0.00153	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	7.5e-05	0.00153	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	7.5e-05	0.00153	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	7.45e-05	0.00152	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	7.45e-05	0.00152	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TNF—pancreatic cancer	7.4e-05	0.00151	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	7.35e-05	0.0015	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	7.35e-05	0.0015	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	7.34e-05	0.0015	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	7.29e-05	0.00149	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	7.29e-05	0.00149	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	7.2e-05	0.00147	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	7.19e-05	0.00147	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	7.07e-05	0.00145	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	7.05e-05	0.00144	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	7.04e-05	0.00144	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	6.93e-05	0.00142	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	6.92e-05	0.00141	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	6.83e-05	0.0014	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	6.81e-05	0.00139	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	6.79e-05	0.00139	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	6.77e-05	0.00138	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	6.69e-05	0.00137	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	6.68e-05	0.00137	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	6.67e-05	0.00136	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	6.65e-05	0.00136	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	6.54e-05	0.00134	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	6.42e-05	0.00131	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	6.42e-05	0.00131	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.41e-05	0.00131	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	6.38e-05	0.0013	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	6.36e-05	0.0013	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	6.29e-05	0.00129	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	6.28e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	6.28e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	6.25e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	6.25e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	6.24e-05	0.00128	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	6.15e-05	0.00126	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	6.11e-05	0.00125	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	6.11e-05	0.00125	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	6.07e-05	0.00124	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	6.01e-05	0.00123	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	5.94e-05	0.00121	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	5.88e-05	0.0012	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	5.87e-05	0.0012	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	5.79e-05	0.00118	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	5.75e-05	0.00117	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	5.67e-05	0.00116	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	5.57e-05	0.00114	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	5.57e-05	0.00114	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	5.45e-05	0.00111	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	5.45e-05	0.00111	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	5.41e-05	0.0011	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	5.31e-05	0.00109	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PRSS1—pancreatic cancer	5.27e-05	0.00108	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	5.2e-05	0.00106	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	5.18e-05	0.00106	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	5.18e-05	0.00106	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	5.17e-05	0.00106	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	5.09e-05	0.00104	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	5.06e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	5.06e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	5.06e-05	0.00103	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	5.02e-05	0.00103	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	4.98e-05	0.00102	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	4.94e-05	0.00101	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.88e-05	0.000998	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	4.87e-05	0.000995	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.84e-05	0.000989	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	4.83e-05	0.000987	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	4.76e-05	0.000973	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.71e-05	0.000964	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	4.64e-05	0.000949	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	4.61e-05	0.000943	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	4.59e-05	0.000937	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ARG2—pancreatic cancer	4.57e-05	0.000934	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	4.54e-05	0.000928	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	4.51e-05	0.000922	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	4.49e-05	0.000917	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	4.4e-05	0.0009	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	4.4e-05	0.0009	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	4.37e-05	0.000894	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	4.31e-05	0.00088	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	4.31e-05	0.00088	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	4.26e-05	0.00087	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	4.03e-05	0.000823	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TYMP—pancreatic cancer	3.99e-05	0.000816	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.97e-05	0.000811	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	3.94e-05	0.000805	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	3.94e-05	0.000805	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	3.92e-05	0.000802	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.92e-05	0.000801	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.91e-05	0.000799	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.88e-05	0.000794	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	3.85e-05	0.000788	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	3.84e-05	0.000784	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.83e-05	0.000783	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	3.71e-05	0.000759	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.65e-05	0.000746	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	3.63e-05	0.000743	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.62e-05	0.00074	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.61e-05	0.000737	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	3.59e-05	0.000733	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	3.53e-05	0.000721	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	3.51e-05	0.000717	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.49e-05	0.000713	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	3.42e-05	0.0007	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.41e-05	0.000698	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	3.37e-05	0.000689	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	3.35e-05	0.000684	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.33e-05	0.00068	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	3.3e-05	0.000674	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GLP1R—pancreatic cancer	3.22e-05	0.000658	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.22e-05	0.000658	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.17e-05	0.000648	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—DPYD—pancreatic cancer	3.17e-05	0.000647	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	3.1e-05	0.000634	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.04e-05	0.000622	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A2—pancreatic cancer	3e-05	0.000614	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.98e-05	0.000608	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	2.95e-05	0.000604	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.92e-05	0.000598	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	2.89e-05	0.000591	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	2.88e-05	0.00059	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.86e-05	0.000585	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	2.82e-05	0.000577	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.76e-05	0.000565	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.72e-05	0.000555	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.7e-05	0.000552	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	2.65e-05	0.000543	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	2.6e-05	0.000531	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	2.53e-05	0.000517	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	2.47e-05	0.000505	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	2.42e-05	0.000494	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	2.41e-05	0.000493	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	2.36e-05	0.000483	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	2.36e-05	0.000482	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	2.36e-05	0.000482	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CD44—pancreatic cancer	2.33e-05	0.000476	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	2.31e-05	0.000473	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	2.31e-05	0.000472	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	2.26e-05	0.000462	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GCG—pancreatic cancer	2.23e-05	0.000456	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	2.2e-05	0.000449	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	2.18e-05	0.000445	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	2.15e-05	0.00044	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	2.13e-05	0.000435	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	2.13e-05	0.000435	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	2.13e-05	0.000435	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	2.11e-05	0.00043	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—STK11—pancreatic cancer	2.1e-05	0.000429	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	2.08e-05	0.000426	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	2.08e-05	0.000426	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	2.06e-05	0.000421	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	1.94e-05	0.000397	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	1.9e-05	0.000388	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	1.87e-05	0.000383	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.85e-05	0.000379	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	1.83e-05	0.000375	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	1.83e-05	0.000374	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.81e-05	0.000371	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TYMS—pancreatic cancer	1.8e-05	0.000369	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	1.79e-05	0.000367	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.68e-05	0.000344	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.65e-05	0.000337	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	1.63e-05	0.000334	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	1.6e-05	0.000326	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	1.57e-05	0.000321	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	1.56e-05	0.000318	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	1.53e-05	0.000314	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	1.52e-05	0.000312	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	1.51e-05	0.00031	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	1.5e-05	0.000307	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	1.48e-05	0.000303	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	1.47e-05	0.0003	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOE—pancreatic cancer	1.47e-05	0.0003	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	1.46e-05	0.000299	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	1.45e-05	0.000296	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	1.43e-05	0.000292	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	1.42e-05	0.00029	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	1.42e-05	0.000289	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	1.41e-05	0.000288	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	1.39e-05	0.000284	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	1.38e-05	0.000282	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	1.38e-05	0.000281	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	1.35e-05	0.000275	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.32e-05	0.000271	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	1.31e-05	0.000267	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	1.28e-05	0.000261	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARG—pancreatic cancer	1.28e-05	0.000261	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	1.27e-05	0.00026	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	1.26e-05	0.000258	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	1.26e-05	0.000257	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	1.25e-05	0.000255	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	1.23e-05	0.000252	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	1.23e-05	0.000252	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	1.17e-05	0.00024	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	1.17e-05	0.000239	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.16e-05	0.000238	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	1.15e-05	0.000234	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	1.15e-05	0.000234	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	1.14e-05	0.000234	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	1.12e-05	0.000229	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	1.08e-05	0.000221	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	1.06e-05	0.000217	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	0.000207	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.01e-05	0.000205	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	9.95e-06	0.000203	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	9.73e-06	0.000199	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	9.62e-06	0.000197	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	9.41e-06	0.000192	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	9.2e-06	0.000188	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	9e-06	0.000184	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTEN—pancreatic cancer	8.77e-06	0.000179	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	8.13e-06	0.000166	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	7.95e-06	0.000162	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CA—pancreatic cancer	6.19e-06	0.000126	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—pancreatic cancer	5.05e-06	0.000103	CbGpPWpGaD
